Medicina
Facultad
Academic Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de Academic Medical Center (274)
2024
-
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 2, pp. 696-715
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy
-
High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery
European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85
-
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 3, pp. 194-202
-
The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial
Journal of Critical Care, Vol. 79
-
The science of micronutrients in clinical practice – Report on the ESPEN symposium
Clinical Nutrition
2023
-
A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 9, pp. 2497-2509
-
A Travel Through Time: Percutaneous Management of Degenerated Coronary Saphenous Vein Grafts
JACC: Case Reports, Vol. 10
-
Abnormal physiological findings after FFR-based revascularisation deferral are associated with worse prognosis in women
Scientific Reports, Vol. 13, Núm. 1
-
Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry
International Journal of Cardiology, Vol. 392
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)
Intensive Care Medicine
-
Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial (Surgical Endoscopy, (2023), 37, 9, (7317-7324), 10.1007/s00464-023-10278-5)
Surgical Endoscopy
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment
European Heart Journal - Digital Health, Vol. 4, Núm. 4, pp. 291-301
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076
-
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
European Respiratory Journal, Vol. 61, Núm. 4
-
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632